79 - Late Breaker Abstract Session: Respiratory Viruses Across All Ages

Moderator(s)

• 

  Judith Guzman-Cottrill, DO (she/her/hers)

  Professor, Pediatric Infectious Diseases
  Oregon Health & Science University
  Portland, OR, United States
• 

  Taison Bell, MD, MBA

  Associate Professor of Medicine
  UVA Health

Presentations:

• 1:45 PM – 1:57 PM US PT

  Effectiveness of Adjuvanted Inactivated Influenza Vaccine versus High-Dose Inactivated Influenza Vaccine Against PCR-Confirmed Influenza among Adults ≥65 years: A Pragmatic Randomized Study
  

  Co-Author: Amber Hsiao, MPH – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Arnold Yee, MA – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Thomas Leong, MPH – Kaiser Permanente Northern California

  Co-Author: Ousseny Zerbo, PhD – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Bruce Fireman, MA – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Karen B. Jacobson, MD, MPH – Kaiser Permanente Vaccine Study Center

  Co-Author: John R. Hansen, MPH – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Evan Layefsky, BA – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Mendel Haag, PhD, PharmD – CSL Seqirus

  Co-Author: Ian McGovern, MPH (he/him/his) – CSL Seqirus

  Co-Author: Bin Zhang, ScD, MA – CSL Seqirus

  Co-Author: Juliet Dang, PhD, MS – CSL Seqirus

  Presenting Author: Nicola P. Klein, MD, PhD (she/her/hers) – Division of Research Kaiser Permanente Vaccine Study Center
• 1:57 PM – 2:09 PM US PT

  Real-world Abrysvo Vaccine Effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related Severe Acute Respiratory Infection (ARI) Hospitalizations and Emergency Department (ED) Visits—Kaiser Permanente of Southern California (KPSC), November 2023–April 2024
  

  Presenting Author: Sara Y. Tartof, PhD MPH – Kaiser Permanente Southern California

  Co-Author: Negar Aliabadi, MD, MS – Pfizer

  Co-Author: Gabriella Goodwin, MS – Kaiser Permanente, Southern California

  Co-Author: Jeff Slezak, MS – Kaiser Permanente Southern California

  Co-Author: Vennis Hong, MPH – Kaiser Permanente

  Co-Author: Bradley Ackerson, MD (he/him/his) – Kaiser Permanente Southern California

  Co-Author: Qing Liu, M.S. – Pfizer Inc.

  Co-Author: Sally Shaw, DrPH, MPH – Kaiser Permanente Southern California

  Co-Author: Sabrina Welsh, MPH – Pfizer, Inc

  Co-Author: Julie Stern, MPH – Kaiser Permanente Southern California

  Co-Author: Banshri Kapadia, MS – Kaiser Permanente, Southern California

  Co-Author: Brigitte Spence, MPH – Kaiser Permanente Southern California

  Co-Author: Joe Lewnard, PhD – University of California, Berkeley

  Co-Author: Gregory Davis, MPH, PhD – Kaiser Permanente, Southern California

  Co-Author: Michael Aragones, MD – Kaiser Permanente Southern California

  Co-Author: Michael Dutro, PharmD – Pfizer

  Co-Author: Erica Chilson, PharmD – Pfizer

  Co-Author: Elisa Gonzalez, MS – Pfizer

  Co-Author: Robin Hubler, MS – Pfizer Inc.

  Co-Author: Ashley Miller, MA, CCRP – Pfizer

  Co-Author: Brandon Chia, n/a – Kaiser Permanente School of Medicine

  Co-Author: Luis Jodar, PhD – Pfizer Vaccines

  Co-Author: Bradford D. Gessner, M.D., M.P.H. – Pfizer Biopharma Group

  Co-Author: Elizabeth Begier, MD, M.P.H. – Pfizer Vaccines
• 2:09 PM – 2:21 PM US PT

  A Phase 2b/3 Study to Evaluate the Efficacy and Safety of an Investigational Respiratory Syncytial Virus (RSV) Antibody, Clesrovimab, in Healthy Preterm and Full-Term Infants
  

  Co-Author: Heather J. Zar, PhD – Red Cross Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa

  Co-Author: Eric Simoes, MD DCH – University of Colorado School of Medicine and Colorado School of Public Health

  Co-Author: Sabhir Madhi, MD – Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit

  Co-Author: Octavio Ramilo, MD – St. Jude Children's Research Hospital

  Co-Author: Shelly Senders, MD – Senders Pediatrics, Cleveland, Ohio, United States

  Co-Author: Julie S. Shepard, MD, MPH – Ohio Pediatric Research Association

  Co-Author: Kamolwish Laoprasopwattana, MD – Prince of Songkla University

  Co-Author: Jorge Piedrahita, MD – Clinica de la Costa

  Co-Author: Jose M. Novoa Pizarro, MD – Hospital Padre Alberto Hurtado

  Co-Author: Sergio L. Vargas, MD – University Chile School of Medicine

  Co-Author: Marc Dionne, MD – CHU de Quebec-Universite Laval

  Co-Author: Teresa Jackowska, MD – Center of Postgraduate Medical Education & Bielanski Hospital

  Co-Author: Enmei Liu, MD – Children's Hospital of Chongqing Medical University

  Co-Author: Yasunori Ishihara, MD, PhD – Fukui Aiiku Hospital

  Co-Author: Kazushige Ikeda, MD – Saitama City Hospital

  Co-Author: Ying Zhang, PhD – Merck & Co., Inc.

  Co-Author: Radha A. Railkar, PhD – Merck & Co., Inc.

  Co-Author: Jeannine Lutkiewicz, BS – Merck & Co., Inc.

  Co-Author: Andrew W. Lee, MD – Merck & Co., Inc., present affiliation Uniquity Bio, Malvern, PA, USA

  Co-Author: Andrea Guerra, MD (he/him/his) – Merck Sharp & Dohme LLC - United Kingdom

  Presenting Author: Anushua Sinha, MD, MPH – Merck and Co Inc.
• 2:21 PM – 2:33 PM US PT

  Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease
  

  Co-Author: Heather J. Zar, PhD – Red Cross Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa

  Co-Author: Louis J. Bont, MD – University Medical Centre Utrecht

  Co-Author: Paolo Manzoni, MD, PhD – University of Torino

  Co-Author: Flor M. Munoz, MD, MSc – Baylor College of Medicine

  Presenting Author: Octavio Ramilo, MD – St. Jude Children's Research Hospital

  Co-Author: Po-Yen Chen, MD – Taichung Veterans General Hospital

  Co-Author: Jose M. Novoa Pizarro, MD – Hospital Padre Alberto Hurtado

  Co-Author: Gustavo A. Ordonez, MD – Univeridad Del Valle

  Co-Author: Maria Tsolia, MD, PhD – National and Kapodistrian University of Athens

  Co-Author: Bruce Tapiero, MD – CHU Sainte-Justine

  Co-Author: Mirta Acuña, MD – Roberto del rio children hospital

  Co-Author: Javier M. Castellanos, MD – Morales Vargas Centro de Investigacion

  Co-Author: Michael Meyer, MD – Middlemore Hospital

  Co-Author: Ichiro Morioka, MD, PhD – Nihon University Itabashi Hospital

  Co-Author: Ziqiang Chen, PhD – Merck & Co., Inc.

  Co-Author: Radha A. Railkar, PhD – Merck & Co., Inc.

  Co-Author: Xiaowei Zang, PhD – Merck & Co., Inc.

  Co-Author: Andrea L. Krick, PhD – Merck & Co., Inc.

  Co-Author: Andrew W. Lee, MD – Merck & Co., Inc., present affiliation Uniquity Bio, Malvern, PA, USA

  Co-Author: Luis A. Castagnini, MD, MPH – Merck & Co., Inc.

  Co-Author: Anushua Sinha, MD, MPH – Merck and Co Inc.
• 2:33 PM – 2:45 PM US PT

  Safety, Reactogenicity, and Immunogenicity of mRNA-1345, an Investigational Respiratory Syncytial Virus Vaccine, in Participants Aged 2 to < 18 Years at High Risk of Severe Disease
  

  Presenting Author: Sabine Schnyder Ghamloush, MD (she/her/hers) – Moderna, Inc.

  Co-Author: Hui Qian, PhD – Moderna, Inc.

  Co-Author: HuiLing Chen, PhD – Moderna, Inc.

  Co-Author: Joseph Whitten, MD – Moderna, Inc.

  Co-Author: Sonia K. Stoszek, PhD – Moderna, Inc.

  Co-Author: Matthew D. Snape, MBBS, MD, FRCPCH, FPM, FMedSci – Moderna Biotech UK, Inc
• 2:45 PM – 2:57 PM US PT

  Universal Immunization Strategy Against Respiratory Syncytial Virus (RSV) Prevention in Chile with Nirsevimab during the 2024 Winter Season: First Southern Hemisphere Nationwide Effectiveness Data
  

  Presenting Author: Juan P. Torres, Medical Doctor, PhD – Universidad de Chile

  Co-Author: Denis Saure, PhD – Universidad de Chile

  Co-Author: Miguel O´Ryan, MD – Universidad de Chile

  Co-Author: Marcel Goic, PhD – Universidad de Chile

  Co-Author: Charles Thraves, PhD – Universidad de Chile

  Co-Author: Natalia Trigo, Ing – Universidad de Chile

  Co-Author: Gonzalo Diaz, Ing – Universidad de Chile

  Co-Author: Jorge Pacheco, MD, MS – Ministerio de Salud de Chile

  Co-Author: Javiera Burgos, MS – Ministerio de Salud de Chile

  Co-Author: Patricio Aguilera, Ing – Ministerio de Salud de Chile

  Co-Author: Leonardo Basso, Eng, PhD – Universidad de Chile